Cullman, ALABAMA3 Active Studies

Pulmonary Embolism Clinical Trials in Cullman, ALABAMA

Find 3 actively recruiting pulmonary embolism clinical trials in Cullman, ALABAMA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,393
Enrolling

Recruiting Pulmonary Embolism Studies in Cullman

About Pulmonary Embolism Clinical Trials in Cullman

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 3 pulmonary embolism clinical trials recruiting participants in Cullman, ALABAMA. These studies are seeking a combined 1,393 participants. Research is being sponsored by Novo Nordisk A/S, Vertex Pharmaceuticals Incorporated, Zealand Pharma. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Cullman — FAQ

Are there pulmonary embolism clinical trials in Cullman?

Yes, there are 3 pulmonary embolism clinical trials currently recruiting in Cullman, ALABAMA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cullman?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cullman research site will contact you about next steps.

Are clinical trials in Cullman free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cullman studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 3 active trials in Cullman are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated March 2, 2026 from ClinicalTrials.gov